Skip to main content
. 2017 Oct 10;14:34. doi: 10.1186/s12014-017-9169-6

Fig. 4.

Fig. 4

Proteins that showed an increasing trend in Proseek® values in the four patient groups. The logarithmic output of the top 12 biomarkers that showed an increasing trend in values from healthy, to benign, to early stage serous ovarian cancer, to late stage serous ovarian cancer were graphed as quantile plots: CA125, HE4, MK, KLK6, hK11, CXCL13, FR-alpha, IL-6, TNFSF14, FADD, PRSS8, and FUR. Outliers are defined as any value higher or lower than 1.5 multiplied by the interquartile range. A complete ranking of all 92 proteins is shown in Additional file 1